One of the most significant limitations of conventional psychiatric treatment is the time it takes to work — weeks for antidepressants to reach therapeutic effect, weeks more to assess whether a particular medication is working, and the real clinical danger that a person in acute distress does not have weeks to wait. Research from the National Institute of Mental Health (2024) has identified ketamine as a rapid-acting option offering new hope specifically for patients who have not responded to standard care — and for suicidal ideation in particular, the speed of ketamine’s effect is not a secondary feature. It may be the primary one. At Mend The Mind in Livingston, Montana, we offer IV ketamine therapy for adults experiencing suicidal ideation as part of a comprehensive psychiatric care plan.
The Clinical Problem Ketamine Addresses
Suicidal ideation — thoughts of ending one’s life, ranging from passive wishes to die to active plans — is a psychiatric emergency when acute, and a persistent, debilitating symptom when chronic. It frequently accompanies major depressive disorder, PTSD, bipolar disorder, and other conditions, and it does not always resolve even when the underlying condition is being treated. For patients managing chronic suicidal ideation as a feature of treatment-resistant illness, the options that conventional care offers are limited — and the gap between the urgency of the symptom and the timeline of standard treatment is a genuine clinical problem, not a patient management issue.
Standard antidepressants can reduce suicidal ideation over time as depression improves. But they require weeks to take effect, and they do not directly address the neurobiological state associated with acute suicidal crisis. This is the gap that the research on ketamine and suicidal ideation speaks to directly.
At Mend The Mind, we evaluate and treat adults experiencing suicidal ideation as part of a structured, supervised clinical plan. This is not a service for patients in acute crisis requiring emergency intervention — if you are in immediate danger, please call or text 988 or go to your nearest emergency room now. For patients managing suicidal ideation as an ongoing symptom of a psychiatric condition, IV ketamine therapy may offer rapid, clinically meaningful relief while longer-term treatment takes effect.
Why Speed Matters in Suicidal Ideation
The National Institute of Mental Health has documented that ketamine restores pleasure-seeking behavior — anhedonia, or the inability to experience pleasure or motivation, is one of the most distressing features of severe depression and suicidal states — ahead of other antidepressant actions. This finding is significant because it suggests ketamine addresses core features of the suicidal state, not merely peripheral symptoms, and does so on a timeline that no conventional antidepressant can match.
The mechanism involves ketamine’s action on NMDA receptors — N-methyl-D-aspartate receptors — in the glutamate system, the brain’s primary excitatory neurotransmitter network. Rather than gradually shifting serotonin availability over weeks, ketamine triggers rapid changes in synaptic plasticity — the brain’s ability to form and modify neural connections — that can produce measurable improvements in mood and suicidal thinking within hours to days of a single infusion. For patients who have been unable to access a future-oriented perspective, who have lost the neurological capacity for relief to feel real or near, that speed can be genuinely significant.
Individual results vary. Not every patient experiencing suicidal ideation will respond to ketamine therapy, and response does not constitute a cure or a permanent resolution of the underlying condition. What the research supports is that ketamine may meaningfully reduce the intensity and persistence of suicidal thinking in patients for whom other treatments have not been sufficient — and that this effect can emerge on a clinically urgent timeline.
Ketamine as Part of a Comprehensive Plan
IV ketamine therapy for suicidal ideation at Mend The Mind is not offered as a standalone intervention in isolation from broader psychiatric care. Suicidal ideation is a symptom of underlying conditions — most commonly depression, bipolar disorder, or PTSD — that require comprehensive clinical management. Ketamine can reduce the intensity of ideation and create a window of neuroplastic openness during which longer-acting treatments can take root, but it does not address the full clinical picture on its own.
For patients currently working with a psychiatrist, therapist, or other mental health provider, we coordinate with your existing care team and do not position ketamine therapy as a replacement for those relationships. Discuss with your provider whether IV ketamine therapy is an appropriate addition to your current treatment plan and what coordination of care should look like for your specific situation.
Every patient at Mend The Mind undergoes a thorough evaluation before any treatment is scheduled. This includes a careful review of your psychiatric history, current symptoms and their severity, previous treatment responses, support system, and safety planning. Cassidy Boyer — our founder, a Board Certified Registered Nurse Anesthesiologist and PMHNP candidate completing her post-master’s training at Montana State University, and a USAF veteran with experience treating individuals who have lived through significant trauma and loss — conducts this evaluation with both clinical rigor and genuine understanding of what chronic suicidal ideation costs a person over time.
What Treatment Looks Like
IV ketamine infusions at Mend The Mind are administered in a private treatment room in Livingston with continuous monitoring of heart rate, blood pressure, and oxygen levels throughout every session. Cassidy is present from the placement of the IV line through recovery. Mental health infusions typically last 40 to 60 minutes.
Our standard initial protocol is six infusions over two to three weeks. For patients experiencing suicidal ideation, the National Institute of Mental Health’s research on ketamine’s rapid antidepressant action is particularly relevant — some patients report meaningful reduction in ideation within hours to days of an early session, though the full clinical picture emerges across the complete initial series. We monitor your response between sessions and remain accessible if your symptom picture changes acutely.
The days following each infusion represent a period of heightened neuroplastic activity — a window during which the brain is particularly receptive to forming new patterns and consolidating shifts in how future, safety, and possibility feel. Supporting this window through rest, reduced demands, and where appropriate, integration with your broader care team, helps sustain the shifts that ketamine initiates.
For patients who complete an initial IV series and are looking for ongoing maintenance support, we prescribe ketamine troches — at-home dissolvable lozenges under our continued medical supervision. Troches are generally not suited to acute suicidal ideation, which responds best to the more rapid and robust effect of IV administration. They are more appropriate as a maintenance option once an initial IV response has been established and the acute phase of ideation has reduced.
Addressing Stigma Around Suicidal Ideation
One of the most persistent barriers to care for patients experiencing suicidal ideation is the fear of how disclosing it will be received — by providers, by family, by institutions. That fear is not irrational. Patients have had experiences in which disclosing suicidal thoughts resulted in responses that felt punitive, dismissive, or that removed their agency from their own care. Those experiences create understandable reluctance to raise the symptom again with a new provider.
We approach disclosure of suicidal ideation the way we approach all clinical information: as information that helps us care for you more accurately, not as a trigger for an automatic institutional response. Our goal is to understand your experience, assess your current safety, and have a transparent clinical conversation about what appropriate care looks like for your situation. That conversation requires honesty from both sides, and we hold up our end of it.
If shame or past negative experiences with disclosure are part of what is making it difficult to seek care, we want you to know that those experiences are common, that they do not reflect the standard of care you deserve, and that this clinic is a different kind of conversation.
Addressing Cost
Pricing at Mend The Mind is discussed during consultation and is not published on our website, because treatment plans vary and a single figure would not accurately represent your individual situation. We are an out-of-network provider. Through the Osmind care management platform, every patient receives a detailed superbill following each session that can be submitted to their insurance company for potential out-of-network reimbursement. We recommend contacting your insurer before your first appointment to ask about your out-of-network benefits for ketamine therapy. Coverage outcomes vary by plan.
We are committed to making the financial side of treatment fully transparent before any commitment is made. If cost is a barrier to even scheduling a consultation, please contact us — we would rather talk through the financial realities directly than have cost be the reason a patient in genuine need does not pursue care.
Frequently Asked Questions
Is IV ketamine appropriate if I am currently in acute suicidal crisis?
No. Acute suicidal crisis requiring immediate intervention calls for emergency services — please call or text 988 or go to your nearest emergency room. IV ketamine therapy at Mend The Mind is an outpatient treatment for adults managing suicidal ideation as a persistent symptom of an underlying psychiatric condition, once acute safety has been established and a structured clinical plan is in place.
How quickly might ketamine reduce suicidal thoughts?
Research from the National Institute of Mental Health documents ketamine’s rapid antidepressant action, with some patients experiencing meaningful symptom reduction within hours to days of an early infusion. Results vary by individual, and we monitor your response throughout the treatment series rather than drawing conclusions from a single session.
Does ketamine therapy for suicidal ideation require me to stop my other psychiatric medications?
Not necessarily. Whether your current medications continue, are adjusted, or are paused during ketamine therapy depends on your specific regimen and clinical history. This is reviewed thoroughly during your evaluation. Do not adjust or discontinue any medications without guidance from your prescribing provider.
Can ketamine therapy help even if my suicidal ideation is chronic rather than acute?
Yes. Chronic suicidal ideation accompanying treatment-resistant conditions is the patient population for which ketamine therapy at Mend The Mind is most relevant. The research on ketamine’s rapid antidepressant effects has included patients with persistent suicidal ideation, and meaningful reduction in that symptom is among the effects documented. Results vary by individual.
What safety measures are in place during treatment?
Every session includes continuous monitoring of your vital signs by a Board Certified CRNA throughout the infusion. Cassidy is present with you from the placement of the IV line through recovery. We conduct a safety assessment prior to treatment and remain accessible between sessions if your symptom picture changes. Safety is not an afterthought in how we practice — it is the foundation of every clinical decision we make.
Key Takeaways
- Suicidal ideation frequently persists despite conventional psychiatric treatment, and the weeks-long timeline of standard antidepressants represents a genuine clinical gap for patients in acute or chronic distress.
- Research from the National Institute of Mental Health documents ketamine’s rapid antidepressant action — including restoration of pleasure-seeking behavior ahead of other antidepressant effects — on a timeline that may be clinically significant for patients experiencing suicidal ideation.
- IV ketamine therapy for suicidal ideation at Mend The Mind is offered as part of a comprehensive, supervised clinical plan — not as a standalone intervention — and requires thorough evaluation of your safety, history, and current clinical circumstances.
- Stigma around disclosing suicidal ideation is a real and common barrier; at Mend The Mind, disclosure is treated as clinical information that improves your care, handled with directness and without punitive assumptions.
- Results vary by individual. Ketamine therapy may offer meaningful, rapid relief for chronic suicidal ideation in appropriate candidates — and if you are in immediate danger, please call or text 988 or go to your nearest emergency room now.
Conclusion
For patients managing suicidal ideation as a persistent, inadequately treated symptom of a psychiatric condition, the research on ketamine therapy represents one of the more meaningful clinical developments in recent years — not because it resolves the underlying illness, but because it may reduce the most urgent and dangerous feature of that illness on a timeline that conventional treatments cannot match. Results vary by individual, and an honest clinical evaluation is the necessary first step. If you are not in immediate crisis and want to explore whether IV ketamine therapy may be appropriate for your situation, we are ready to have that conversation. Call us at 406-350-4439, email mendthemindmt@gmail.com, or request a consultation through our website. If you are in crisis right now, please call or text 988 or go to your nearest emergency room.
References
National Institute of Mental Health. Rapid-Acting Depression Treatment (2024). https://www.nimh.nih.gov/news/science-updates/2024/new-hope-for-rapid-acting-depression-treatment
National Institute of Mental Health. Rapid Antidepressant Action. https://www.nimh.nih.gov/news/science-updates/2014/rapid-agent-restores-pleasure-seeking-ahead-of-other-antidepressant-action
Medical Disclaimer
The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy for suicidal ideation should only be pursued under the supervision of a qualified, licensed healthcare provider who is familiar with your full medical and psychiatric history. Individual results vary, and Mend The Mind does not guarantee specific outcomes from any treatment. This blog is not a substitute for emergency psychiatric care. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline, or go to your nearest emergency room immediately.